Unknown

Dataset Information

0

KI and WU Polyomavirus in Respiratory Samples of SARS-CoV-2 Infected Patients.


ABSTRACT: Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) has been declared a global pandemic. Our goal was to determine whether co-infections with respiratory polyomaviruses, such as Karolinska Institutet polyomavirus (KIPyV) and Washington University polyomavirus (WUPyV) occur in SARS-CoV-2 infected patients. Oropharyngeal swabs from 150 individuals, 112 symptomatic COVID-19 patients and 38 healthcare workers not infected by SARS-CoV-2, were collected from March 2020 through May 2020 and tested for KIPyV and WUPyV DNA presence. Of the 112 SARS-CoV-2 positive patients, 27 (24.1%) were co-infected with KIPyV, 5 (4.5%) were positive for WUPyV, and 3 (2.7%) were infected simultaneously by KIPyV and WUPyV. Neither KIPyV nor WUPyV DNA was detected in samples of healthcare workers. Significant correlations were found in patients co-infected with SARS-CoV-2 and KIPyV (p < 0.05) and between SARS-CoV-2 cycle threshold values and KIPyV, WUPyV and KIPyV and WUPyV concurrently detected (p < 0.05). These results suggest that KIPyV and WUPyV may behave as opportunistic respiratory pathogens. Additional investigations are needed to understand the epidemiology and the prevalence of respiratory polyomavirus in COVID-19 patients and whether KIPyV and WUPyV could potentially drive viral interference or influence disease outcomes by upregulating SARS-CoV-2 replicative potential.

SUBMITTER: Prezioso C 

PROVIDER: S-EPMC8229673 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC9031565 | biostudies-literature
| S-EPMC3816538 | biostudies-literature
| S-EPMC7108349 | biostudies-literature
| S-EPMC7389920 | biostudies-literature
| S-EPMC7172307 | biostudies-literature
| S-EPMC2662633 | biostudies-literature
| S-EPMC2815986 | biostudies-literature
| S-EPMC2919546 | biostudies-literature
| S-EPMC3294973 | biostudies-literature
| S-EPMC7106500 | biostudies-literature